Summary
Research published in Nature suggests that purines can act as endogenous molecular glues in human cells, anchoring a rate-limiting enzyme in purine biosynthesis to its inhibitor. Modifying this mechanism could potentially improve the properties of thiopurine chemotherapeutic drugs.